SCHEMBL20368697

SCHEMBL20368697

C=CSc1ncc(NC(=O)C2CCCCCCCCC2)c(C2CCCCCCCC2)c1C=C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.41
HDAC1 Q13547 3/20 0.41
HDAC2 Q92769 3/20 0.41
CETP P11597 1/20 0.39
ABL1 P00519 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
PTPN1 P18031 2/20 0.36
PTPN2 P17706 1/20 0.36
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
ALOX15 P16050 1/20 0.34
HTT P42858 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19059690 1.00 HDAC3 (0.41) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL18399552 1.00 HDAC3 (0.41) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL18399591 0.81 HDAC3 (0.45) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL22853573 0.81 HDAC3 (0.42) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL19059670 0.81 HDAC3 (0.42) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL18399589 0.81 HDAC3 (0.42) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL20368736 0.81 HDAC3 (0.42) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL22138732 0.76 HDAC1 (0.49) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL22018238 0.71 CDK2 (0.46) HDAC3HDAC1HDAC2CETPABL1
SCHEMBL21157774 0.71 CDK2 (0.46) HDAC3HDAC1HDAC2CETPABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10265307-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2019-04-23 US disclosed
US-20180193323-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10265307-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors PIM2, PIM1, PIM3 HDAC3 487/4885HDAC1 359/4885HDAC2 532/4885
US-20180193323-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 HDAC3 487/4885HDAC1 359/4885HDAC2 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.